FLUENCE CORPORATION LIMITED — Director's Dealing 2016

Apr 18, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01	Amended 01/01/11
Name of entity	Emefcy Group Limited (ASX: EMC)
ABN	52 127 734 196

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

irector for the purposes of section 205G of	the Corporations Act.
Name of Director	Eytan Levy
Date of last notice	29 December 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest	Beneficial owner of ordinary shares held in the name
(including registered holder)Note: Provide details of the circumstances giving rise to the	of ESOP Management and Trust Services Ltd.
relevant interest.
Date of change	12 April 2016
No. of securities held prior to change	6,409,416 ordinary shares held in the name of ESOP
	Management and Trust Services Ltd.
	1,000,000 options with exercise price of $0.30,
	expiring 18/12/18
	1,000,000 options with exercise price of $0.40,
	expiring18/12/2019
Class	Ordinary shares held in the name of ESOP
	Management and Trust Services Ltd. (escrowed until
	23 December 2017)
Number acquired	2,858,394
Number disposed	Not applicable

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation	Part of the deferred consideration for the Company’sacquisition of Emefcy Limited, Israel.
No. of securities held after change	9,267,810 ordinary shares held in the name of ESOPManagement and Trust Services Ltd.1,000,000 options with exercise price of $0.30,expiring 18/12/181,000,000 options with exercise price of $0.40,expiring 18/12/2019
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,	Ordinary shares issued as part consideration, uponsatisfaction of the first commercial milestone underthe Share Purchase Agreement. The issue of thisdeferredconsiderationwasapprovedbytheCompany’s shareholders at a general meeting on 17November 2015.
participation in buy-back	the Share Purchase Agreement. The issue of thisdeferredconsiderationwasapprovedbytheCompany’s shareholders at a general meeting on 17November 2015.
art 2 – Change of director’s interests in contracts

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Share Purchase Agreement, the terms of which weresummarised in section 13.1(a) of the Company’sReplacement Prospectus dated 23 October 2015.	Share Purchase Agreement, the terms of which weresummarised in section 13.1(a) of the Company’sReplacement Prospectus dated 23 October 2015.	Share Purchase Agreement, the terms of which weresummarised in section 13.1(a) of the Company’sReplacement Prospectus dated 23 October 2015.
Nature of interest	In accordance with the terms of the Share PurchaseAgreement, a right to receive shares in the Company asdeferred consideration for the acquisition of EmefcyLimited,Israel.
	deferredLimited	,consideration for the acquisition of EmefcyIsrael
		,.
Name of registered holder(if issued securities)	Not app	licable
Date of change	12 Apri	2016
No. and class of securities to whichinterest related prior to change	Up to asatisfact	total of 5,962,945 ordinary shares followingion of prescribed milestones (summarised in
Note: Details are only required for a contract in relationto which the interest has changed	section 13.6 of the Company’s Replacement Prospectus
Interest acquired	Not applicable
Interest disposed	2,858,394 ordinary shares were issued as a result of thesatisfaction of the first milestone.
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	Part of the deferred consideration for the Company’sacquisition of Emefcy Limited, Israel.
Interest after change	Up to a total of 3,104,551 ordinary shares followingsatisfaction of prescribed milestones (summarised insection 13.6 of the Company’s Replacement Prospectusdated 23 October 2015).

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above	No
traded during a+closed period where prior written clearance
was required?
If so, was prior written clearance provided to allow the trade to	Not applicable
proceed during this period?
If prior written clearance was provided, on what date was this	Not applicable
provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3